Rates of complete response to the novel CAR-T varied from 67% to 75% across the 4 dosage levels tested.
Nicholas Wrigley
Advertisement
Articles by Nicholas Wrigley
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
M. Peter Marinkovich, MD, on Integrating Gene Therapy into Clinical Practice for Dermatologists
2
Quarter Century Update: How can Partnerships Between Academia, Biotech, and Pharma be Better Structured?
3
Quarter Century Update: The Continued Unknowns of Cell and Gene Therapy
4
